A Homeopathic Disaster: Case Report of Turpentine Toxicity (P4.399)
Citation Manager Formats
Make Comment
See Comments

Abstract
Background: Turpentine toxicity is not well known and only a handful of case reports are published. Turpentine is used by some as homeopathic treatment of intestinal parasites. Turpentine is very dangerous and can result in serious complications including multiorgan failure, encephalitis, and death. Case Presentation: 48 year old male with a past medical history of Grave’s disease, ocular myasthenia gravis, ITP, chronic diarrhea and a recent diagnosis of extra-pontine myelinolysis, who presented with four days of fever, vomiting, and diarrhea. Patient was transferred from another hospital where he was admitted with these symptoms and found to have a serum sodium of 106. Patient’s sodium was rapidly corrected which resulted in the development of rigidity and tremors with bilateral basal ganglia T2 hyperintensities on MRI confirming extra-pontine myelinolysis. Upon transfer, patient became obtunded and hemodynamically unstable. Infectious, metabolic, and endocrine etiologies were thoroughly evaluated but work-up was negative. Laboratory values were significant for thrombocytopenia, hypolipoproteinemia, and depressed levels of complement. It was not until a nurse saw the patient’s brother giving the patient homeopathic medications that we learned of his ingestion of turpentine and determined its likely role in our patient’s condition. Conclusions: Turpentine is obtained from the distillation of tree resin. It is used topically for treatment of lice, or orally for intestinal parasite eradication. In research, turpentine is used in animal models to induce systemic inflammation by up-regulating pro-inflammatory cytokines. It is also found to substantially reduce cholesterol. Toxicity results in gastroenteritis, kidney failure, respiratory failure, hemodynamic instability, encephalitis and coma. We propose that patient’s acute illness was secondary to turpentine toxicity and likely contributed to patient’s autoimmune co-morbidities given its association of inducing a pro-inflammatory state. It is very important to obtain history of homeopathic medications and educate the community about the risks involved with unregulated medications.
Disclosure: Dr. MacCallum has nothing to disclose. Dr. Towfighi has nothing to disclose.
Tuesday, April 19 2016, 8:30 am-7:00 pm
- Copyright © 2016 by AAN Enterprises, Inc.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.